Chapter 1217: Chapter 1221: Relax the Inclusion Criteria!
On Saturday morning, Chen Cang and a group of more than ten people gathered in the discussion room.
The head of the Cardiothoracic Surgery Departnt, Xu Ziming, was reporting the situation.
“We analyzed a variety of indicators such as efficacy and safety for the first phase surgery patients, and the results show…”
“Our team’s average operation ti is about 5 minutes less than the current mainstream surgeries. However, if Teacher Chen performs the surgery, it might save even more ti, but… this cannot be used in our clinical analysis results.”
“From the perspectives of efficacy and safety analysis, efficacy is still the criteria for determining surgical outcos, and we have already reached the level reported at the 2019 World Large Vessel Conference.”
“In terms of safety… it mainly involves two aspects, firstly mortality, and secondly complications. Since our inclusion criteria are quite strict, we have not yet started studying mortality; our primary focus has been on exploring complications.”
“The probability of complications has already been reduced compared to the data from 2019 due to our efforts in surgery ti.”
After Xu Ziming disclosed the data, everyone at the scene couldn’t help but cheer!
After all, their efforts have not been wasted.
This data ans that they can now proceed with clinical surgeries.
They have now reached the current national average level.
Even Chen Cang is genuinely happy inside.
He couldn’t help but start applauding, giving applause to their team mbers.
Until now, Chen Cang hasn’t been personally involved in every single surgery.
On the contrary, he is helping their team mbers, performing surgeries together with them.
Because one person’s capability is ultimately limited.
Up to now, in the initial group of twelve team mbers, there are already five or six who can complete surgeries, including Li Baoshan, Xu Ziming, He Zhiqian, Liu Quan, and others.
They are the backbone of the first batch!
Progress is fast.
However, what intrigues Chen Cang the most is Xu Aiqing; she is the most diligent and fastest progressing mber in the team.
For her child, Xu Aiqing is really working desperately.
Everyone is very happy and excited.
Their success ans being able to save more patients.
But…
The surgery of the first-phase patients has just ended, signifying the beginning of a new phase.
At this ti, Xu Ziming said, “Teacher Chen, for the second-phase cases, how do you plan to proceed?”
The room quieted down at that mont.
During the first phase, they followed strict criteria and inclusion standards and achieved significant therapeutic results.
What about the second phase?
How should it evolve?
After a mont of contemplation, Chen Cang lightly said, “For the second phase, relax the inclusion criteria and conduct mortality rate research!”
As soon as this statent was made, the surroundings imdiately fell silent.
Mortality rate research!
Everyone’s hearts couldn’t help but tremble.
Mortality rate studies have always been an area no discipline wants to touch upon.
What people talk about as ‘efficacy’ is not the actual efficacy.
And the efficacy defined by how to include criteria.
This is an inaccurate piece of data.
But real-life scenarios are much harsher than data.
Just like the research on mortality rates, that is the case.
It is entirely about relaxing case inclusion criteria and studying mortality rates.
At that thought, everyone couldn’t help but look towards Chen Cang.
Isn’t this… a bit too hasty?
After all, the first phase has laid such a solid foundation… Is it… a pity to squander it!
Thinking about this, everyone felt a bit heartbroken.
Because loosening the inclusion criteria now and proceeding with an effectiveness and complications analysis for 100 cases, it’s clear that the data will definitely decline compared to the first phase.
Both safety and effectiveness rates are going to decrease!
This great hand that started off so well, are we really going to ruin it?
Everyone felt a bit restless and uneasy.
Xu Ziming couldn’t help but say, “Mr. Chen… isn’t this too much of a pity!”
“Our first phase achieved such good results, anyone would surely continue with follow-up refinent research, further improving the effectiveness rate and safety, reducing complications, then our data…”
Chen Cang remained composed and casually asked, “What use do we have for this data? Good looking data is useless!
“When we initiated this project, surely our goal wasn’t just to obtain a set of beautiful clinical data, right?”
“Our primary objective is still to save lives!”
Everyone fell silent.
Chen Cang’s words were quite right, but… there was still so reluctance.
Everyone is doing this, we can do it too!
After all… there’s a difference between clinical trials and actual surgery.
We can’t just exclude a patient because they don’t et the inclusion criteria and deny them surgery.
If so, our research would be aningless.
But…
Everyone still felt it was a pity.
Thinking of An Jing, thinking of Ruijin.
Their ergency centers also want to have a prestigious departnt, celebrated nationwide, renowned worldwide.
But, that’s clearly not sothing that happens overnight.
Right now, the clinical research on Marfan patients undergoing thoracoabdominal aortic replacent surgery itself is very promising, once the results co out, it’s clearly worthy of awards!
But…
Chen Cang’s sudden brainstorm made the whole team feel sowhat regretful.
Honestly speaking, if Chen Cang didn’t change the policy, didn’t change the direction, and just proceeded with the surgeries as planned, such results could win awards!
Alas…
Everyone couldn’t help but sigh.
“Mr. Chen, we… I still think we should improve the effectiveness rates, after all, we have co so far already, suddenly loosening the inclusion criteria, the mortality rate, complication probability will shoot up, it will be hard for us to lower these factors!” He Zhiqian also wanted to make a case.
Chen Cang suddenly smiled: “Can’t we loosen the inclusion criteria and talk about the treatnt rate? Or can’t we loosen the inclusion criteria to study the probability of complications? Moreover, it can also include the mortality rate!”
“In that case, the proportion will drastically reduce!” Xu Ziming couldn’t help but say.
Chen Cang shook his head: “This data will be more realistic and will also be more applicable to ordinary patients, which will help the dical field even more.”
“Moreover, who says that our rates will definitely decrease?”
His words left everyone dumbfounded!
It will definitely decrease!
Loosening the inclusion criteria, the patient’s risk factors will greatly increase, the most dangerous aspect of Marfan syndro being sudden major vessel rupture, dying on the operating table.
But, what did Mr. Chen an just now?
Could it be…
Mr. Chen already has a better thod?
Reviews
All reviews (0)